Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arduino Arduini

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
American Journal of Hematology|September 2, 2006
Cellular properties of human erythrocytes preserved in saline-adenine-glucose-mannitol in the presence of L-carnitineArduino Arduini, Giampaolo Minetti, Annarita Ciana, et al.
Journal of Medicinal Chemistry|January 10, 2003
Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activityFabio Giannessi, Pompeo Pessotto, Emanuela Tassoni, et al.
Drug Design, Development and Therapy|December 10, 2016
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cellsMario Bonomini, Sara Di Silvestre, Pamela Di Tomo, et al.
Blood Transfusion = Trasfusione Del Sangue|August 15, 2012
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprintVittorio Sirolli, Claudia Rossi, Augusto Di Castelnuovo, et al.
Kidney International|April 29, 2011
L-carnitine is an osmotic agent suitable for peritoneal dialysisMario Bonomini, Assunta Pandolfi, Lorenzo Di Liberato, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 29, 2024
Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysisMario Bonomini, Simon Davies, Werner Kleophas, et al.
Cardiovascular Research|May 30, 2025
Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, Arduino Arduini, et al.
Scientific Reports|September 13, 2018
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cellsRosalba Florio, Laura De Lellis, Serena Veschi, et al.
Kidney & Blood Pressure Research|August 28, 2024
Rationale and Design of PURE: A Randomized Controlled Trial to Evaluate Peritoneal Ultrafiltration with PolyCore™ in Refractory Congestive Heart FailureEdoardo Gronda, Maurizio Gallieni, Giuseppe Pacileo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 4, 2013
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trialMario Bonomini, Lorenzo Di Liberato, Goffredo Del Rosso, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
American Journal of Hematology|September 2, 2006
Cellular properties of human erythrocytes preserved in saline-adenine-glucose-mannitol in the presence of L-carnitineArduino Arduini, Giampaolo Minetti, Annarita Ciana, et al.
Journal of Medicinal Chemistry|January 10, 2003
Discovery of a long-chain carbamoyl aminocarnitine derivative, a reversible carnitine palmitoyltransferase inhibitor with antiketotic and antidiabetic activityFabio Giannessi, Pompeo Pessotto, Emanuela Tassoni, et al.
Drug Design, Development and Therapy|December 10, 2016
Effect of peritoneal dialysis fluid containing osmo-metabolic agents on human endothelial cellsMario Bonomini, Sara Di Silvestre, Pamela Di Tomo, et al.
Blood Transfusion = Trasfusione Del Sangue|August 15, 2012
Toward personalized hemodialysis by low molecular weight amino-containing compounds: future perspective of patient metabolic fingerprintVittorio Sirolli, Claudia Rossi, Augusto Di Castelnuovo, et al.
Kidney International|April 29, 2011
L-carnitine is an osmotic agent suitable for peritoneal dialysisMario Bonomini, Assunta Pandolfi, Lorenzo Di Liberato, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|August 29, 2024
Rationale and design of ELIXIR, a randomized, controlled trial to evaluate efficacy and safety of XyloCore, a glucose-sparing solution for peritoneal dialysisMario Bonomini, Simon Davies, Werner Kleophas, et al.
Cardiovascular Research|May 30, 2025
Sweeteners: erythritol, xylitol and cardiovascular risk-friend or foe?Bettina K Wölnerhanssen, Anne Christin Meyer-Gerspach, Arduino Arduini, et al.
Scientific Reports|September 13, 2018
Effects of dichloroacetate as single agent or in combination with GW6471 and metformin in paraganglioma cellsRosalba Florio, Laura De Lellis, Serena Veschi, et al.
Kidney & Blood Pressure Research|August 28, 2024
Rationale and Design of PURE: A Randomized Controlled Trial to Evaluate Peritoneal Ultrafiltration with PolyCore™ in Refractory Congestive Heart FailureEdoardo Gronda, Maurizio Gallieni, Giuseppe Pacileo, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|June 4, 2013
Effect of an L-carnitine-containing peritoneal dialysate on insulin sensitivity in patients treated with CAPD: a 4-month, prospective, multicenter randomized trialMario Bonomini, Lorenzo Di Liberato, Goffredo Del Rosso, et al.
Pageof 6